rs118083394 - MEGF9

Magnitude 4.5 · 1 study on file

Reported associations

  • Role of the Complement System in Chronic Central Serous Chorioretinopathy: A Genome-Wide Association Study. - JAMA ophthalmology (2019) · Schellevis RL, van Dijk EHC, Breukink MB, Altay L, Bakker B, Koeleman BPC, Kiemeney LA, Swinkels DW, Keunen JEE, Fauser S, Hoyng CB, den Hollander AI, Boon CJF, de Jong EK · PubMed 30073298

    To date, several targeted genetic studies on chronic central serous chorioretinopathy (cCSC) have been performed; however, unbiased genome-wide studies into the genetics of cCSC have not been reported. To discover new genetic loci associated with cCSC and to better understand the causative mechanism of this disease, we performed a genome-wide association study (GWAS) on patients with cCSC. To discover new genetic loci and pathways associated with cCSC and to predict the association of genetic variants with gene expression in patients with cCSC. This case-control GWAS was completed in the general community, 3 referral university medical centers, and outpatient care on Europeans individuals with cCSC and population-based control participants. Genotype data was collected from May 2013 to Augu


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Screening

  • ophthalmology screening for retinal disease Moderate

    MEGF9 rs118083394 associated with chronic central serous retinopathy in GWAS

    discuss genetic risk with ophthalmologist and obtain baseline fundus examination